by Syrma Johari MedTech | Nov 20, 2025 | Blog
In high-risk medical device manufacturing, quality serves as a foundational operating principle that defines commercial success and regulatory readiness. Thus, treating Quality Assurance and Regulatory Affairs (QARA) as a downstream function can be a costly mistake...
by Syrma Johari MedTech | Nov 14, 2025 | Blog
Tariff engineering is the legitimate practice of designing a product, its components, or its classification to ensure that, upon import, it qualifies for a lower tariff rate. This is not tariff evasion—it is a deliberate, commercially sound, and technically defensible...
by Syrma Johari MedTech | Nov 14, 2025 | Blog
Medical devices are built on globally distributed value chains: for example, sensors from Japan, plastics from Mexico, electronics from Asia, final assembly in the U.S. or EU, and post-market service worldwide. For much of the last three decades, this ecosystem scaled...
by Syrma Johari MedTech | Nov 5, 2025 | Blog
Post-COVID, in vitro diagnostic (IVD) has transitioned from episodic use to being integral across precision medicine, preventive care, and consumer health. The pandemic drove unprecedented demand, with the global IVD market surging by 45.4% in value from 2019 to 2020....
by Syrma Johari MedTech | Oct 31, 2025 | News and Events
Syrma Johari MedTech Limited (SJML), a leading medical device design and manufacturing partner, announced the successful conclusion of its participation in The MedTech Conference 2025 (AdvaMed), held from October 6–8, 2025, in the United States. Hosted by AdvaMed,...
